<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib58">
 <label>58.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Burton</surname>
    <given-names>D.R.</given-names>
   </name>
   <name>
    <surname>Desrosiers</surname>
    <given-names>R.C.</given-names>
   </name>
   <name>
    <surname>Doms</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Feinberg</surname>
    <given-names>M.B.</given-names>
   </name>
   <name>
    <surname>Gallo</surname>
    <given-names>R.C.</given-names>
   </name>
   <name>
    <surname>Hahn</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Public health. A sound rationale needed for phase III HIV-1 vaccine trials</article-title>
  <source>Science</source>
  <volume>303</volume>
  <year>2004</year>
  <fpage>16</fpage>
 </element-citation>
</ref>
